Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of personalized medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

Jun 21, 2021

Pierre Pellier is CEO of CTMA and is driven to provide better access to innovative and potentially life-saving therapies to more patients. The key is to shorten the duration of clinical trials by more quickly and efficiently identifying and recruiting potentially eligible participants.

Using the CT-Scout platform on a...


Jun 21, 2021

Pierre Pellier is CEO of CTMA and is driven to provide better access to innovative and potentially life-saving therapies to more patients. The key is to shorten the duration of clinical trials by more quickly and efficiently identifying and recruiting potentially eligible participants.

Using the CT-Scout platform on a...


Jun 17, 2021

Mike Rea is the Founder and CEO of IDEA Pharma and Founder of Protodigm, created to develop a new way of progressing drug development. With a fundamental understanding of what goes wrong in early-stage pharmaceutical development, Mike is eager to do more diverse opportunity-seeking for assets in early phase trials. The...


Jun 17, 2021

Mike Rea is the Founder and CEO of IDEA Pharma and Founder of Protodigm, created to develop a new way of progressing drug development. With a fundamental understanding of what goes wrong in early-stage pharmaceutical development, Mike is eager to do more diverse opportunity-seeking for assets in early phase trials. The...


Jun 15, 2021

Renee Agular-Lucander is CEO of Calliditas Therapeutics a Sweden-based clinical-stage biopharmaceutical company focused on the rare kidney disease IgA nephropathy. While there is a genetic predisposition for this autoimmune disease, it is still not clear what triggers the condition and there is no current cure.

Renee...